Hyperparathyroidism in Patients with Chronic Renal Failure Shortens the Action of Vecuronium
The duration of vecuronium in anephric patients is known to have interpatient variability. It was reported that primary hyperparathyroidism attenuated the action of atracurium. The interpatient variability may be in part due to the degree of parathyroid function. We evaluated the effect of secondary hyperparathyroidism on the duration of vecuronium in patients with chronic renal failure.